Active, not recruitingEarly Phase 1NCT04037605

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

Studying Multiple endocrine neoplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Principal Investigator
Peter Liu, MD, PhD
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Intervention
Ketoconazole Pill (also known as nizoral)(drug)
Enrollment
5 enrolled
Eligibility
60-80 years · All sexes
Timeline
2020 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04037605 on ClinicalTrials.gov

Other trials for Multiple endocrine neoplasia

Additional recruiting or active studies for the same condition.

See all trials for Multiple endocrine neoplasia →

← Back to all trials